National Cheng Kung University Hospital ( Site 1202)

Tainan 704

0 studies enrolling now · 2 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) — Completed
• Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009) — Completed